Immune Biosolutions Inc., a JLABS @ Toronto resident company, has entered a research collaboration and license agreement with Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement, facilitated by Johnson & Johnson Innovation LLC, will focus initially on the discovery and development of therapeutic antibodies in oncology. The collaboration will utilize IBio’s proprietary…